Navigation Links
StockCall Scrutinizes Pfizer, Merck & Co., Johnson & Johnson, and AbbVie
Date:4/10/2013

with its Relative Strength Index at 70.18. Consequently, the stock may see some pullback in the coming sessions. It closed its Tuesday's session at $45.51, up 0.07 percent. The stock is currently in a bullish mode and may touch $45.67 level in the coming days. Upon breaching this level, the stock's next resistance price is at $47.96. the drug maker's stock has low volatility with its beta at 0.58. So far in 2013, the stock appreciated 11.98 percent. Its 52 weeks gain stands at 17.05 percent. The stock has traded in the range of $37.02 and $48 during the said time period. Register for today's free analysis on MRK at

http://www.StockCall.com/MRK041013.pdf

Johnson & Johnson extended its 52 weeks gain by closing 0.51 percent higher. The stock ended Tuesday's session at $81.52, while its highest price point for the session stood at $81.75. It traded 9.08 million shares, down from its average daily volume of 9.98 million. Johnson & Johnson traded in the range of $61.71 and $82.95 in the past 52 weeks, and currently it is trading near its high price point. The company commands market capitalization of $228.01 billion and it reported its latest EPS at $3.86. Johnson & Johnson's stock gained more than 24 percent in the past 52 weeks. Free report on JNJ can be accessed by registering at

http://www.StockCall.com/JNJ041013.pdf

AbbVie Inc. traded up with above average volume to end its latest session at $42.55. The stock ended 1.87 percent higher than its previous close. Its volume for the day stood at 8.67 million shares. The stock is currently trading marginally lower than its 20-day SMA of $42.58 and its 50-day SMA of $42.77. Its first resistance level is at $42.87 while it may tumble down to $42.33 before receiving any support. AbbVie's stock is up 23.26 percent on a YTD basis, while offering 3.76 percent dividend yield. Register
'/>"/>

SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Leaders from Pfizer, Novartis and J&J Challenge Industry to Disrupt R&D
2. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
3. Ambrx Collaborates with Merck to Design and Develop Biologic Drug Conjugates
4. Merck Company Foundation Announces HIV Care Collaborative with Atlanta, Houston and Philadelphia Health Departments
5. Symphogen Grants Exclusive Worldwide License of Phase II Oncology Drug Candidate Sym004 to Merck KGaA
6. Merck Serono et lInstitut Feinstein vont sassocier pour développer un programme pré-clinique portant sur les maladies inflammatoires
7. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
8. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
9. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
10. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
11. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 2015 , ... Pittcon is pleased to announce that the ... chemical spectroscopic imaging at JASIS 2015 (Japan Analytical & Scientific Instruments Show) ... instruments show which will be held at International Conference Hall in Makuhari Messe, ...
(Date:8/28/2015)... ... August 28, 2015 , ... Riordan-McKenna ... McKenna, DO, announced today that the use of sterile, dehydrated amniotic tissue AlphaPATCH™ ... of an otherwise non-healing surgical knee wound. , The case involved a 78-year-old ...
(Date:8/27/2015)... ... August 27, 2015 , ... The ... funds, investment firms and animal health companies to hear from animal health companies ... Several have also received licensing agreements or distribution contracts. This meeting is ...
(Date:8/27/2015)... -- Neogen Corporation (NASDAQ: NEOG ) announced today that ... Kingdom -based Lab M Holdings, a developer, manufacturer ... Lab M was founded in 1971, ... testing and diagnostic products for the global food, water, ... into more than 70 countries worldwide, and has several ...
Breaking Biology Technology:U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 2U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Neogen acquires U.K.-based Lab M Holdings 2
... settled in for the,winter months and since the common ... days of school and work, now is the time ... Immunity Enhanced Beverage is designed,to do just that. , ... Products, Immunity Enhanced,Beverage is a ready-to-drink liquid supplement intended ...
... Turbulent EconomyOAKBROOK TERRACE, Ill., Jan. 7 AeA, the ... the high-tech industry, announced today that the NASDAQ OMX ... outperformed the Dow Jones Industrial Average (.INDU), S&P 500, ... 2008.On May 19, 2008, AeA and The NASDAQ Stock ...
... YORK, Jan. 7 Aisling Capital announced today that ... newest life sciences fund, Aisling Capital III, LP. Aisling ... developing pharmaceutical, biopharmaceutical and medical products, as well as ... important services to the healthcare industry. With a total ...
Cached Biology Technology:Innovative Beverage Products Launches New Product Designed to Enhance the Body's Immune Defense 2NASDAQ OMX AeA Illinois Tech Index Outperforms Market 2NASDAQ OMX AeA Illinois Tech Index Outperforms Market 3Aisling Capital Announces Close of US$650M Life Sciences Fund 2
(Date:8/12/2015)... , Aug. 12, 2015  New research unveiled ... attack Android phones to steal users, fingerprints. Information ... availability of fingerprint scanners on mobile devices, making ... To secure biometrics on mobile devices, HYPR Corp. ... these convenient authentication systems with strong cryptographic security. ...
(Date:8/10/2015)... and TELTOW, Germany , August 10, ... (SMI), a world leader in Eye Tracking Technology for ... its OEM Eye Tracking Platform for integration into all ... contains reference designs for seamless integration of eye tracking ... reality HMDs and augmented reality smart glasses. Omnivision,s leading ...
(Date:8/6/2015)... Germany , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking ... Epson,s Moverio BT-200 see-through head mounted display and on ... unprecedented quality and efficiency is brought to personalized visualization ... the first time, professionals and researchers can integrate gaze, ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... - Researchers from the University of Pennsylvania and ... $14.6 million contract from the National Institute of Allergy ... of Health, to expand and extend work on the ... This revolutionary open database enables scientists to examine genes, ...
... us like sport in the physical education classes we ... education teaching staff must develop the responsibility, encourage social ... objective is to make us feel capable of doing ... The objective of the study recently published ...
... (December 10, 2009) Pathological gambling can be ... increase inhibitions, according to researchers at the annual ... Researchers found positive outcomes in gamblers treated ... People with pathological gambling disorder will ...
Cached Biology News:Penn, Georgia collaboration awarded $14.6 million to expand pathogen database 2Penn, Georgia collaboration awarded $14.6 million to expand pathogen database 3Physical education teaching staff play key role in making you like sport 2Pathological gambling may be successfully treated with medications for substance addiction 2
... II RNA gel stain is a sensitive ... when bound to RNA and low background in ... formaldehyde/agarose or polyacrylamide gels using laser scanners or ... A 1 mL unit size (S-7568) and a ...
RORgamma (S-14)...
... designed for your specific applications and built ... synthesis platform. Thousands of customer specified sequences ... can provide assistance with custom sequence design. ... our comprehensive Custom DNA Microarray Service. ...
... designed for RNA aptamer screening and binding ... powerful Paraflo microfluidic on-chip synthesis platform. These ... comprehensive DNA/RNA Aptamer Microarray Service. ... Aptamer Microarray contains greater than 1500 known ...
Biology Products: